Monthly Archives: October 2022

Tirzepatide authorised by MHRA

13th October 2022

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for tirzepatide, a top pharmaceutical company has announced. Eli Lilly and Company has received ...

Read more